# Chennai Meenaks (NSE: CMMHOSP) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/CMMHOSP · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹29 Cr, it ranks 3391st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

Its return on equity was 0.0% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹10 Cr (+7.0% year on year) and net profit −₹0 Cr (−106.5%), on a standalone basis. Promoters held 57.10% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹29 Cr |
| ROE | 0.0% (FY25) |
| ROCE | −5.0% (FY25) |
| Debt to equity | -5.63 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹10 Cr | +7.0% | −₹0 Cr | −106.5% | −₹0.03 |
| Q3 FY26 | ₹9 Cr | +3.2% | −₹1 Cr | — | −₹0.72 |
| Q2 FY26 | ₹9 Cr | +17.3% | ₹0 Cr | — | ₹0.20 |
| Q1 FY26 | ₹9 Cr | −1.1% | −₹1 Cr | — | −₹0.99 |
| Q4 FY25 | ₹9 Cr | −4.0% | ₹0 Cr | — | ₹0.42 |
| Q3 FY25 | ₹9 Cr | +14.5% | −₹1 Cr | — | −₹0.84 |
| Q2 FY25 | ₹8 Cr | +13.7% | −₹1 Cr | −1,775.0% | −₹0.90 |
| Q1 FY25 | ₹9 Cr | +33.8% | −₹0 Cr | −2,000.0% | −₹0.51 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹35 Cr | −₹1 Cr |
| FY24 | ₹38 Cr | −₹0 Cr |
| FY23 | ₹29 Cr | ₹1 Cr |
| FY22 | ₹31 Cr | ₹4 Cr |
| FY21 | ₹19 Cr | −₹1 Cr |
| FY20 | ₹26 Cr | ₹1 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 57.10%
- Domestic institutions: 0.14%
- Non-institutions: 42.76%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Medi-Caps](https://app.pivotnow.in/stock/MEDICAPQ) | ₹25.50 | ₹32 Cr | — | — |
| [KK Shah Hospita](https://app.pivotnow.in/stock/KKSHL) | — | ₹30 Cr | — | — |
| [Panjon](https://app.pivotnow.in/stock/PANJON) | — | ₹30 Cr | — | — |
| [Soni Medicare](https://app.pivotnow.in/stock/SML) | — | ₹30 Cr | — | — |
| [Tejnaksh](https://app.pivotnow.in/stock/TEJNAKSH) | — | ₹29 Cr | — | — |
| [SAMSRITA LABS](https://app.pivotnow.in/stock/SAMSRITA) | — | ₹28 Cr | — | — |

## Questions and answers

### What is the market cap of Chennai Meenaks?

Chennai Meenaks' market capitalisation is ₹29 Cr (₹29 Cr) at the 22 Oct 2026 close, ranking 3391st among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Chennai Meenaks?

Return on equity was 0.0% in FY25 and return on capital employed was −5.0% in FY25 (standalone figures).

### Is Chennai Meenaks a debt-free company?

Chennai Meenaks is close to debt-free: its debt-to-equity ratio was -5.63 in FY25.

### What were Chennai Meenaks' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Chennai Meenaks reported revenue of ₹10 Cr, +7.0% year on year, and net profit of −₹0 Cr, −106.5% year on year.

### What is the shareholding pattern of Chennai Meenaks?

As of 30 Jun 2026: promoters 57.10%, domestic institutions 0.14%, non-institutions 42.76%.

### Who are Chennai Meenaks' competitors?

The listed Pharma & Healthcare companies closest to Chennai Meenaks by market cap are Medi-Caps, KK Shah Hospita, Panjon, Soni Medicare, Tejnaksh and SAMSRITA LABS.

### Is Chennai Meenaks a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Chennai Meenaks' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on CMMHOSP against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.